Verition Fund Management
CNCE

Verition Fund Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Verition Fund Management’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-133,160
Closed -$1.68M – 1841
2020
Q4 		$1.68M Buy
+133,160
New +$1.52M 0.01% 409

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verition Fund Management's CNCE Position: Q1 2021 in Review

Verition Fund Management sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2021, closing a stake of 133,160 shares — an estimated $1.68M sold.

Verition Fund Management first reported a position in CNCE in Q4 2020 and held it in 1 quarter. The position peaked at $1.68M in Q4 2020. 91 funds tracked by Wall St. Rank hold CNCE as of Q1 2021.

  • Verition Fund Management reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
  • Verition Fund Management sold 133,160 Concert Pharmaceuticals, Inc. shares in Q1 2021, an estimated $1.68M.
  • Verition Fund Management first reported a position in Concert Pharmaceuticals, Inc. in Q4 2020 and held it in 1 quarter.
  • Verition Fund Management's Concert Pharmaceuticals, Inc. position peaked at $1.68M in Q4 2020.
  • 91 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2021.

Based on Verition Fund Management's 13F filing for Q1 2021, filed 18 May 2021.